VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $73,000 | -12.0% | 17,691 | 0.0% | 0.02% | -11.5% |
| Q1 2021 | $83,000 | -38.1% | 17,691 | -5.6% | 0.03% | -40.9% |
| Q4 2020 | $134,000 | -33.0% | 18,745 | 0.0% | 0.04% | -42.1% |
| Q3 2020 | $200,000 | +3.1% | 18,745 | +84.6% | 0.08% | +1.3% |
| Q1 2019 | $194,000 | +0.5% | 10,156 | -50.4% | 0.08% | -10.7% |
| Q4 2018 | $193,000 | -50.3% | 20,490 | 0.0% | 0.08% | -39.1% |
| Q3 2018 | $388,000 | -3.0% | 20,490 | 0.0% | 0.14% | 0.0% |
| Q2 2018 | $400,000 | – | 20,490 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |